Global and United States Sickle Cell Disease Drug Market Insights, Forecast to 2027
SKU ID : QYR-18800197 | Publishing Date : 26-Jul-2021 | No. of pages : 153
Detailed TOC of Global and United States Sickle Cell Disease Drug Market Insights, Forecast to 2027
1 Study Coverage1.1 Sickle Cell Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Type
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Drug Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sickle Cell Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Sickle Cell Disease Drug Revenue 2016-2027
2.1.2 Global Sickle Cell Disease Drug Sales 2016-2027
2.2 Global Sickle Cell Disease Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Sickle Cell Disease Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Sickle Cell Disease Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Sickle Cell Disease Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Sickle Cell Disease Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Sickle Cell Disease Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Sickle Cell Disease Drug Revenue Forecast by Region (2022-2027)
3 Global Sickle Cell Disease Drug Competitor Landscape by Players
3.1 Global Top Sickle Cell Disease Drug Manufacturers by Sales
3.1.1 Global Sickle Cell Disease Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Sickle Cell Disease Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Sickle Cell Disease Drug Manufacturers by Revenue
3.2.1 Key Sickle Cell Disease Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Sickle Cell Disease Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Sickle Cell Disease Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Sickle Cell Disease Drug Revenue in 2020
3.2.6 Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Sickle Cell Disease Drug Price by Manufacturers
3.4 Global Sickle Cell Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Sickle Cell Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sickle Cell Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Sickle Cell Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Sickle Cell Disease Drug Market Size by Type (2016-2021)
4.1.1 Global Sickle Cell Disease Drug Sales by Type (2016-2021)
4.1.2 Global Sickle Cell Disease Drug Revenue by Type (2016-2021)
4.1.3 Sickle Cell Disease Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Sickle Cell Disease Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Sickle Cell Disease Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Type (2022-2027)
4.2.3 Sickle Cell Disease Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Sickle Cell Disease Drug Market Size by Application (2016-2021)
5.1.1 Global Sickle Cell Disease Drug Sales by Application (2016-2021)
5.1.2 Global Sickle Cell Disease Drug Revenue by Application (2016-2021)
5.1.3 Sickle Cell Disease Drug Price by Application (2016-2021)
5.2 Sickle Cell Disease Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Sickle Cell Disease Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Sickle Cell Disease Drug Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
6.1.1 United States Sickle Cell Disease Drug Sales YoY Growth 2016-2027
6.1.2 United States Sickle Cell Disease Drug Revenue YoY Growth 2016-2027
6.1.3 United States Sickle Cell Disease Drug Market Share in Global Market 2016-2027
6.2 United States Sickle Cell Disease Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Sickle Cell Disease Drug Players by Sales (2016-2021)
6.2.2 United States Top Sickle Cell Disease Drug Players by Revenue (2016-2021)
6.3 United States Sickle Cell Disease Drug Historic Market Review by Type (2016-2021)
6.3.1 United States Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
6.3.2 United States Sickle Cell Disease Drug Revenue Market Share by Type (2016-2021)
6.3.3 United States Sickle Cell Disease Drug Price by Type (2016-2021)
6.4 United States Sickle Cell Disease Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Sickle Cell Disease Drug Sales Forecast by Type (2022-2027)
6.4.2 United States Sickle Cell Disease Drug Revenue Forecast by Type (2022-2027)
6.4.3 United States Sickle Cell Disease Drug Price Forecast by Type (2022-2027)
6.5 United States Sickle Cell Disease Drug Historic Market Review by Application (2016-2021)
6.5.1 United States Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
6.5.2 United States Sickle Cell Disease Drug Revenue Market Share by Application (2016-2021)
6.5.3 United States Sickle Cell Disease Drug Price by Application (2016-2021)
6.6 United States Sickle Cell Disease Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Sickle Cell Disease Drug Sales Forecast by Application (2022-2027)
6.6.2 United States Sickle Cell Disease Drug Revenue Forecast by Application (2022-2027)
6.6.3 United States Sickle Cell Disease Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
7.2 North America Sickle Cell Disease Drug Market Facts & Figures by Country
7.2.1 North America Sickle Cell Disease Drug Sales by Country (2016-2021)
7.2.2 North America Sickle Cell Disease Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Sickle Cell Disease Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Sickle Cell Disease Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
9.2 Europe Sickle Cell Disease Drug Market Facts & Figures by Country
9.2.1 Europe Sickle Cell Disease Drug Sales by Country (2016-2021)
9.2.2 Europe Sickle Cell Disease Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
10.2 Latin America Sickle Cell Disease Drug Market Facts & Figures by Country
10.2.1 Latin America Sickle Cell Disease Drug Sales by Country (2016-2021)
10.2.2 Latin America Sickle Cell Disease Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sickle Cell Disease Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Sickle Cell Disease Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Acceleron Pharma Inc
12.1.1 Acceleron Pharma Inc Corporation Information
12.1.2 Acceleron Pharma Inc Description and Business Overview
12.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
12.1.5 Acceleron Pharma Inc Recent Development
12.2 Addmedica SAS
12.2.1 Addmedica SAS Corporation Information
12.2.2 Addmedica SAS Description and Business Overview
12.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Addmedica SAS Sickle Cell Disease Drug Products Offered
12.2.5 Addmedica SAS Recent Development
12.3 Angiocrine Bioscience Inc
12.3.1 Angiocrine Bioscience Inc Corporation Information
12.3.2 Angiocrine Bioscience Inc Description and Business Overview
12.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Products Offered
12.3.5 Angiocrine Bioscience Inc Recent Development
12.4 Annexin Pharmaceuticals AB
12.4.1 Annexin Pharmaceuticals AB Corporation Information
12.4.2 Annexin Pharmaceuticals AB Description and Business Overview
12.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Products Offered
12.4.5 Annexin Pharmaceuticals AB Recent Development
12.5 ArQule Inc
12.5.1 ArQule Inc Corporation Information
12.5.2 ArQule Inc Description and Business Overview
12.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ArQule Inc Sickle Cell Disease Drug Products Offered
12.5.5 ArQule Inc Recent Development
12.6 Bio Products Laboratory Ltd
12.6.1 Bio Products Laboratory Ltd Corporation Information
12.6.2 Bio Products Laboratory Ltd Description and Business Overview
12.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Products Offered
12.6.5 Bio Products Laboratory Ltd Recent Development
12.7 Bioverativ Inc
12.7.1 Bioverativ Inc Corporation Information
12.7.2 Bioverativ Inc Description and Business Overview
12.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bioverativ Inc Sickle Cell Disease Drug Products Offered
12.7.5 Bioverativ Inc Recent Development
12.8 bluebird bio Inc
12.8.1 bluebird bio Inc Corporation Information
12.8.2 bluebird bio Inc Description and Business Overview
12.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 bluebird bio Inc Sickle Cell Disease Drug Products Offered
12.8.5 bluebird bio Inc Recent Development
12.9 Bristol-Myers Squibb Co
12.9.1 Bristol-Myers Squibb Co Corporation Information
12.9.2 Bristol-Myers Squibb Co Description and Business Overview
12.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Products Offered
12.9.5 Bristol-Myers Squibb Co Recent Development
12.10 Calimmune Inc
12.10.1 Calimmune Inc Corporation Information
12.10.2 Calimmune Inc Description and Business Overview
12.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Calimmune Inc Sickle Cell Disease Drug Products Offered
12.10.5 Calimmune Inc Recent Development
12.11 Acceleron Pharma Inc
12.11.1 Acceleron Pharma Inc Corporation Information
12.11.2 Acceleron Pharma Inc Description and Business Overview
12.11.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
12.11.5 Acceleron Pharma Inc Recent Development
12.12 CSL Ltd
12.12.1 CSL Ltd Corporation Information
12.12.2 CSL Ltd Description and Business Overview
12.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CSL Ltd Products Offered
12.12.5 CSL Ltd Recent Development
12.13 Daiichi Sankyo Co Ltd
12.13.1 Daiichi Sankyo Co Ltd Corporation Information
12.13.2 Daiichi Sankyo Co Ltd Description and Business Overview
12.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Daiichi Sankyo Co Ltd Products Offered
12.13.5 Daiichi Sankyo Co Ltd Recent Development
12.14 Editas Medicine Inc
12.14.1 Editas Medicine Inc Corporation Information
12.14.2 Editas Medicine Inc Description and Business Overview
12.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Editas Medicine Inc Products Offered
12.14.5 Editas Medicine Inc Recent Development
12.15 Errant Gene Therapeutics LLC
12.15.1 Errant Gene Therapeutics LLC Corporation Information
12.15.2 Errant Gene Therapeutics LLC Description and Business Overview
12.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Errant Gene Therapeutics LLC Products Offered
12.15.5 Errant Gene Therapeutics LLC Recent Development
12.16 Gamida Cell Ltd
12.16.1 Gamida Cell Ltd Corporation Information
12.16.2 Gamida Cell Ltd Description and Business Overview
12.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Gamida Cell Ltd Products Offered
12.16.5 Gamida Cell Ltd Recent Development
12.17 Genethon SA
12.17.1 Genethon SA Corporation Information
12.17.2 Genethon SA Description and Business Overview
12.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Genethon SA Products Offered
12.17.5 Genethon SA Recent Development
12.18 Gilead Sciences Inc
12.18.1 Gilead Sciences Inc Corporation Information
12.18.2 Gilead Sciences Inc Description and Business Overview
12.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Gilead Sciences Inc Products Offered
12.18.5 Gilead Sciences Inc Recent Development
12.19 Global Blood Therapeutics Inc
12.19.1 Global Blood Therapeutics Inc Corporation Information
12.19.2 Global Blood Therapeutics Inc Description and Business Overview
12.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Global Blood Therapeutics Inc Products Offered
12.19.5 Global Blood Therapeutics Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Sickle Cell Disease Drug Industry Trends
13.2 Sickle Cell Disease Drug Market Drivers
13.3 Sickle Cell Disease Drug Market Challenges
13.4 Sickle Cell Disease Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sickle Cell Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Sickle Cell Disease Drug Market Insights, Forecast to 2027
List of TablesTable 1. Global Sickle Cell Disease Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ARQ-092
Table 3. Major Manufacturers of BIVV-003
Table 4. Major Manufacturers of CAL-H
Table 5. Major Manufacturers of CTX-001
Table 6. Major Manufacturers of DRX-194
Table 7. Major Manufacturers of Others
Table 8. Global Sickle Cell Disease Drug Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 9. Global Sickle Cell Disease Drug Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Sickle Cell Disease Drug Sales by Regions (2016-2021) & (K Pcs)
Table 11. Global Sickle Cell Disease Drug Sales Market Share by Regions (2016-2021)
Table 12. Global Sickle Cell Disease Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Sickle Cell Disease Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 14. Global Sickle Cell Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Sickle Cell Disease Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Sickle Cell Disease Drug Sales by Manufacturers (2016-2021) (K Pcs)
Table 18. Global Sickle Cell Disease Drug Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Sickle Cell Disease Drug Manufacturers by Revenue (US$ Million) in 2020
Table 20. Sickle Cell Disease Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Sickle Cell Disease Drug Revenue Share by Manufacturers (2016-2021)
Table 22. Global Sickle Cell Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Drug as of 2020)
Table 24. Key Manufacturers Sickle Cell Disease Drug Price (2016-2021) (USD/Pcs)
Table 25. Sickle Cell Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Sickle Cell Disease Drug Product Type
Table 27. Date of International Manufacturers Enter into Sickle Cell Disease Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Sickle Cell Disease Drug Sales by Type (2016-2021) (K Pcs)
Table 30. Global Sickle Cell Disease Drug Sales Share by Type (2016-2021)
Table 31. Global Sickle Cell Disease Drug Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Sickle Cell Disease Drug Revenue Share by Type (2016-2021)
Table 33. Sickle Cell Disease Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 34. Global Sickle Cell Disease Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 35. Global Sickle Cell Disease Drug Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Sickle Cell Disease Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Sickle Cell Disease Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 39. Global Sickle Cell Disease Drug Sales by Application (2016-2021) (K Pcs)
Table 40. Global Sickle Cell Disease Drug Sales Share by Application (2016-2021)
Table 41. Global Sickle Cell Disease Drug Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Sickle Cell Disease Drug Revenue Share by Application (2016-2021)
Table 43. Sickle Cell Disease Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 44. Global Sickle Cell Disease Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 45. Global Sickle Cell Disease Drug Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Sickle Cell Disease Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Sickle Cell Disease Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 49. United States Sickle Cell Disease Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 50. United States Sickle Cell Disease Drug Sales Share by Company (2016-2021)
Table 51. United States Sickle Cell Disease Drug Revenue (US$ Million) by Company (2016-2021)
Table 52. United States Sickle Cell Disease Drug Revenue Share by Company (2016-2021)
Table 53. United States Sickle Cell Disease Drug Sales (K Pcs) by Type (2016-2021)
Table 54. United States Sickle Cell Disease Drug Sales Share by Type (2016-2021)
Table 55. United States Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. United States Sickle Cell Disease Drug Price (USD/Pcs) by Type (2016-2021)
Table 57. United States Sickle Cell Disease Drug Sales (K Pcs) by Type (2022-2027)
Table 58. United States Sickle Cell Disease Drug Sales Share by Type (2022-2027)
Table 59. United States Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. United States Sickle Cell Disease Drug Revenue Share by Type (2022-2027)
Table 61. United States Sickle Cell Disease Drug Price (USD/Pcs) by Type (2022-2027)
Table 62. United States Sickle Cell Disease Drug Sales (K Pcs) by Application (2016-2021)
Table 63. United States Sickle Cell Disease Drug Sales Share by Application (2016-2021)
Table 64. United States Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. United States Sickle Cell Disease Drug Price (USD/Pcs) by Application (2016-2021)
Table 66. United States Sickle Cell Disease Drug Sales (K Pcs) by Application (2022-2027)
Table 67. United States Sickle Cell Disease Drug Sales Share by Application (2022-2027)
Table 68. United States Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. United States Sickle Cell Disease Drug Revenue Share by Application (2022-2027)
Table 70. United States Sickle Cell Disease Drug Price (USD/Pcs) by Application (2022-2027)
Table 71. North America Sickle Cell Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 72. North America Sickle Cell Disease Drug Sales Market Share by Country (2016-2021)
Table 73. North America Sickle Cell Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Sickle Cell Disease Drug Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Sickle Cell Disease Drug Sales by Region (2016-2021) & (K Pcs)
Table 76. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2016-2021)
Table 79. Europe Sickle Cell Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 80. Europe Sickle Cell Disease Drug Sales Market Share by Country (2016-2021)
Table 81. Europe Sickle Cell Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2016-2021)
Table 83. Latin America Sickle Cell Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 84. Latin America Sickle Cell Disease Drug Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Sickle Cell Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Sickle Cell Disease Drug Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2016-2021) & (K Pcs)
Table 88. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country (2016-2021)
Table 91. Acceleron Pharma Inc Corporation Information
Table 92. Acceleron Pharma Inc Description and Business Overview
Table 93. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 94. Acceleron Pharma Inc Sickle Cell Disease Drug Product
Table 95. Acceleron Pharma Inc Recent Development
Table 96. Addmedica SAS Corporation Information
Table 97. Addmedica SAS Description and Business Overview
Table 98. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 99. Addmedica SAS Product
Table 100. Addmedica SAS Recent Development
Table 101. Angiocrine Bioscience Inc Corporation Information
Table 102. Angiocrine Bioscience Inc Description and Business Overview
Table 103. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 104. Angiocrine Bioscience Inc Product
Table 105. Angiocrine Bioscience Inc Recent Development
Table 106. Annexin Pharmaceuticals AB Corporation Information
Table 107. Annexin Pharmaceuticals AB Description and Business Overview
Table 108. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 109. Annexin Pharmaceuticals AB Product
Table 110. Annexin Pharmaceuticals AB Recent Development
Table 111. ArQule Inc Corporation Information
Table 112. ArQule Inc Description and Business Overview
Table 113. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 114. ArQule Inc Product
Table 115. ArQule Inc Recent Development
Table 116. Bio Products Laboratory Ltd Corporation Information
Table 117. Bio Products Laboratory Ltd Description and Business Overview
Table 118. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 119. Bio Products Laboratory Ltd Product
Table 120. Bio Products Laboratory Ltd Recent Development
Table 121. Bioverativ Inc Corporation Information
Table 122. Bioverativ Inc Description and Business Overview
Table 123. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 124. Bioverativ Inc Product
Table 125. Bioverativ Inc Recent Development
Table 126. bluebird bio Inc Corporation Information
Table 127. bluebird bio Inc Description and Business Overview
Table 128. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 129. bluebird bio Inc Product
Table 130. bluebird bio Inc Recent Development
Table 131. Bristol-Myers Squibb Co Corporation Information
Table 132. Bristol-Myers Squibb Co Description and Business Overview
Table 133. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 134. Bristol-Myers Squibb Co Product
Table 135. Bristol-Myers Squibb Co Recent Development
Table 136. Calimmune Inc Corporation Information
Table 137. Calimmune Inc Description and Business Overview
Table 138. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 139. Calimmune Inc Product
Table 140. Calimmune Inc Recent Development
Table 141. CRISPR Therapeutics Corporation Information
Table 142. CRISPR Therapeutics Description and Business Overview
Table 143. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 144. CRISPR Therapeutics Product
Table 145. CRISPR Therapeutics Recent Development
Table 146. CSL Ltd Corporation Information
Table 147. CSL Ltd Description and Business Overview
Table 148. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 149. CSL Ltd Product
Table 150. CSL Ltd Recent Development
Table 151. Daiichi Sankyo Co Ltd Corporation Information
Table 152. Daiichi Sankyo Co Ltd Description and Business Overview
Table 153. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 154. Daiichi Sankyo Co Ltd Product
Table 155. Daiichi Sankyo Co Ltd Recent Development
Table 156. Editas Medicine Inc Corporation Information
Table 157. Editas Medicine Inc Description and Business Overview
Table 158. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 159. Editas Medicine Inc Product
Table 160. Editas Medicine Inc Recent Development
Table 161. Errant Gene Therapeutics LLC Corporation Information
Table 162. Errant Gene Therapeutics LLC Description and Business Overview
Table 163. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 164. Errant Gene Therapeutics LLC Product
Table 165. Errant Gene Therapeutics LLC Recent Development
Table 166. Gamida Cell Ltd Corporation Information
Table 167. Gamida Cell Ltd Description and Business Overview
Table 168. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 169. Gamida Cell Ltd Product
Table 170. Gamida Cell Ltd Recent Development
Table 171. Genethon SA Corporation Information
Table 172. Genethon SA Description and Business Overview
Table 173. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 174. Genethon SA Product
Table 175. Genethon SA Recent Development
Table 176. Gilead Sciences Inc Corporation Information
Table 177. Gilead Sciences Inc Description and Business Overview
Table 178. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 179. Gilead Sciences Inc Product
Table 180. Gilead Sciences Inc Recent Development
Table 181. Global Blood Therapeutics Inc Corporation Information
Table 182. Global Blood Therapeutics Inc Description and Business Overview
Table 183. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 184. Global Blood Therapeutics Inc Product
Table 185. Global Blood Therapeutics Inc Recent Development
Table 186. Sickle Cell Disease Drug Market Trends
Table 187. Sickle Cell Disease Drug Market Drivers
Table 188. Sickle Cell Disease Drug Market Challenges
Table 189. Sickle Cell Disease Drug Market Restraints
Table 190. Sickle Cell Disease Drug Customers List
Table 191. Sickle Cell Disease Drug Distributors List
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Sickle Cell Disease Drug Product Picture
Figure 2. Global Sickle Cell Disease Drug Sales Market Share by Type in 2020 & 2027
Figure 3. ARQ-092 Product Picture
Figure 4. BIVV-003 Product Picture
Figure 5. CAL-H Product Picture
Figure 6. CTX-001 Product Picture
Figure 7. DRX-194 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Sickle Cell Disease Drug Sales Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Sickle Cell Disease Drug Report Years Considered
Figure 14. Global Sickle Cell Disease Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Sickle Cell Disease Drug Market Size 2016-2027 (US$ Million)
Figure 16. Global Sickle Cell Disease Drug Sales 2016-2027 (K Pcs)
Figure 17. Global Sickle Cell Disease Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Sickle Cell Disease Drug Sales Market Share by Region (2016-2021)
Figure 19. Global Sickle Cell Disease Drug Sales Market Share by Region in 2020
Figure 20. Global Sickle Cell Disease Drug Revenue Market Share by Region (2016-2021)
Figure 21. Global Sickle Cell Disease Drug Revenue Market Share by Region in 2020
Figure 22. Global Sickle Cell Disease Drug Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Sickle Cell Disease Drug Revenue in 2020
Figure 24. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Figure 26. Global Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 27. Global Sickle Cell Disease Drug Revenue Market Share by Type (2016-2021)
Figure 28. Global Sickle Cell Disease Drug Revenue Market Share by Type in 2020
Figure 29. Global Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Figure 30. Global Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 31. Global Sickle Cell Disease Drug Revenue Market Share by Application (2016-2021)
Figure 32. Global Sickle Cell Disease Drug Revenue Market Share by Application in 2020
Figure 33. United States Sickle Cell Disease Drug Sales Growth Rate 2016-2027 (K Pcs)
Figure 34. United States Sickle Cell Disease Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. United States Sickle Cell Disease Drug Market Share in Global Market 2016-2027
Figure 36. United States 5 and 10 Largest Sickle Cell Disease Drug Players Market Share by Revenue in Sickle Cell Disease Drug in 2020
Figure 37. United States Sickle Cell Disease Drug Revenue Share by Type (2016-2021)
Figure 38. United States Sickle Cell Disease Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 39. United States Sickle Cell Disease Drug Revenue Share by Application (2016-2021)
Figure 40. United States Sickle Cell Disease Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Sickle Cell Disease Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 42. North America Sickle Cell Disease Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Sickle Cell Disease Drug Sales Market Share by Country in 2020
Figure 44. North America Sickle Cell Disease Drug Revenue Market Share by Country in 2020
Figure 45. U.S. Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. U.S. Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 48. Canada Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Sickle Cell Disease Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 50. Europe Sickle Cell Disease Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Sickle Cell Disease Drug Sales Market Share by Country in 2020
Figure 52. Europe Sickle Cell Disease Drug Revenue Market Share by Country in 2020
Figure 53. Germany Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. Germany Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. France Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. U.K. Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Italy Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 62. Russia Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Sickle Cell Disease Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 64. Asia Pacific Sickle Cell Disease Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region in 2020
Figure 66. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region in 2020
Figure 67. China Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. China Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. Japan Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. South Korea Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. India Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Australia Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Taiwan Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Indonesia Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Thailand Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Malaysia Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Philippines Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Vietnam Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Sickle Cell Disease Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 90. Latin America Sickle Cell Disease Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Sickle Cell Disease Drug Sales Market Share by Country in 2020
Figure 92. Latin America Sickle Cell Disease Drug Revenue Market Share by Country in 2020
Figure 93. Mexico Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Mexico Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Brazil Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Argentina Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Sickle Cell Disease Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 100. Middle East and Africa Sickle Cell Disease Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country in 2020
Figure 103. Turkey Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 104. Turkey Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 106. Saudi Arabia Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. UAE Sickle Cell Disease Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 108. UAE Sickle Cell Disease Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Sickle Cell Disease Drug Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
Keyplayers in Global and United States Sickle Cell Disease Drug Market Insights, Forecast to 2027
Acceleron Pharma IncAddmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc